Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06608667
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-06-11
Brief Title:
The Clinical Study Aims to Assess the Quality of Donor Livers Using Hyperspectral Imaging
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Evaluation of Ischemia-reperfusion Injury in the Donor Liver Can Be Achieved Through the Utilization of Noninvasive Near-infrared Hyperspectral Imaging
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Based on hyperspectral imaging equipment this project collected hyperspectral imaging data of donor livers analyzed various parameters investigated the detection capability of hyperspectral imaging for assessing donor liver quality gathered patient prognosis information examined the correlation between early postoperative complications and hyperspectral imaging data and explored characteristic parameters for evaluating donor liver quality using hyperspectral imaging technology The occurrence of early complications was predicted
Detailed Description:
Hyperspectral imaging HSI is an advanced optical technology that combines spectroscopy and imaging providing a non-destructive approach for clinical diagnosis In recent years hyperspectral imaging has emerged as a prominent research topic in the field of applied medicine Liver transplantation is considered the most effective treatment for end-stage liver disease however the scarcity of donor livers and the growing number of patients awaiting transplantation pose significant challenges to global organ transplantation The evaluation of donor livers has always been a focal point in liver transplantation Currently clinical evaluation relies heavily on subjective judgment by transplant physicians based on general appearance and touch assessments along with clinical examinations and pathological biopsy results Nevertheless studies have demonstrated that these methods are not entirely reliable for assessing liver quality Therefore it is crucial to identify additional evaluation parameters and establish a convenient reliable and non-invasive method to assess donor liver quality This study aims to analyze hyperspectral imaging data alongside clinical test data and recipient complications occurring between June 2022 to June 2024 to evaluate the quality of donor livers using hyperspectral imaging technology while exploring potential evaluation parameters
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None